The purpose of this study is to gather information on the safety and immunogenicity of an investigational smallpox vaccine in HIV infected populations.

Grants and Contracts Details

StatusFinished
Effective start/end date10/1/0510/31/12

Funding

  • Bavarian Nordic: $176,864.00